Lupin Pharma receives USFDA approval for Fluoxetine

Lupin Pharma has received USFDA approval for its Fluoxetine Tablets USP, 10 mg and 20 mg to market the same in US markets. The drug is a generic version of Eli Lilly and Company’s (Eli Lilly) Prozac Tablets, 10 mg and 20 mg. The drug is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged eight to 18 years, obsessions and compulsions in adult patients and in pediatric patients aged seven to 17 years with Obsessive Compulsive Disorder (OCD), and treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa.

Be the first to comment

Leave a Reply

Your email address will not be published.


*